Methods for testing integrated circuits are provided. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. A second request is transmitted to the server. Alternatively, the location platform can determine whether a SUPL-enabled terminal has an active IP connection from an authentication, authorization, and accounting server. The opening and the aperture are colinearly disposed when the female member is securely engaged with the male member. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via S1P or LPA signaling.